Susquehanna International Group, LLP Savara Inc Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.96 - $5.07 $123,552 - $158,184
-31,200 Reduced 64.6%
17,100 $72,000
Q2 2024

Aug 15, 2024
BUY
$3.66 - $5.34 $124,440 - $181,560
34,000 Added 237.76%
48,300 $194,000
Q1 2024

May 07, 2024
BUY
$4.19 - $5.59 $59,917 - $79,937
14,300 New
14,300 $71,000
Q1 2023

May 16, 2023
BUY
$1.6 - $2.82 $23,520 - $41,454
14,700 New
14,700 $28,000

Others Institutions Holding SVRA

# of Institutions
128
Shares Held
158M
Call Options Held
67.6K
Put Options Held
29.4K
View Full List

About Savara Inc

SVRA Quotes by TradingView
  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $365M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email